Cefsumide

This classification denotes a cephalosporin antibiotic with the molecular formula C17H20N4O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3642W81J7A, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(3-((methylsulfonyl)amino)phenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(r*)))- but more generally known as cefsumide, which bears US NIH Compound Identifier 68718. European Medicines Agency schedules Cefsumide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07421MIG. The term CEFSUMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). CEFSUMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefsumide under HS 29419000 and SITC 54139. As of Q4 2014, CEFSUMIDE remains US FDA's Preferred Term for this commodity. Cefsumide bears US NLM identifiers UMLS ID C0605109 and NCI Concept Code C76037. SMILES: S1C2N(C(=O)C2NC(=O)C(N)C2CC(NS(=O)(=O)C)CCC2)C(=C(C1)C)C(=O)O.